Gabelli Funds LLC Catalent, Inc. Transaction History

Gabelli Funds LLC

$12.8 Billion
Q3 2024

A detailed history of Gabelli Funds LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 408,363 shares of CTLT stock, worth $25.9 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

408,363

Previous 445,671 8.37%

Holding current value

$25.9 Million

Previous $25.1 Million 1.3%

% of portfolio

0.19%

Previous 0.2%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$56.16 - $60.96 $2.1 Million - $2.27 Million	-37,308 Reduced 8.37%	408,363 $24.7 Million
Q2 2024 Aug 13, 2024	SELL	$53.58 - $57.02 $561,304 - $597,341	-10,476 Reduced 2.3%	445,671 $25.1 Million
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $13.8 Million - $19.4 Million	324,147 Added 245.57%	456,147 $25.7 Million
Q3 2023 Nov 08, 2023	BUY	$44.2 - $50.2 $88,400 - $100,400	2,000 Added 1.54%	132,000 $6.01 Million
Q4 2022 Feb 13, 2023	BUY	$41.39 - $81.0 $1.43 Million - $2.79 Million	34,500 Added 36.13%	130,000 $5.85 Million
Q3 2022 Nov 10, 2022	SELL	$72.36 - $113.1 $1.45 Million - $2.26 Million	-20,000 Reduced 17.32%	95,500 $6.91 Million
Q1 2022 May 13, 2022	BUY	$94.19 - $124.49 $3.2 Million - $4.23 Million	34,000 Added 41.72%	115,500 $12.8 Million
Q4 2021 Feb 11, 2022	BUY	$119.57 - $139.07 $1.79 Million - $2.09 Million	15,000 Added 22.56%	81,500 $10.4 Million
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $1.51 Million - $1.74 Million	15,000 Added 29.13%	66,500 $7.19 Million
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $3.2 Million - $3.95 Million	31,500 Added 157.5%	51,500 $5.42 Million
Q4 2020 Feb 05, 2021	BUY	$85.88 - $105.36 $1.72 Million - $2.11 Million	20,000 New	20,000 $2.08 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Account

Gabelli Funds LLC Catalent, Inc. Transaction History